March 21, 2025 - 09:00

CHANDLER, Ariz., March 21, 2025 — Microchip Technology Incorporated, a prominent player in the semiconductor industry, has announced the pricing details for its offering of depositary shares representing interests in its Series A Mandatory Convertible Preferred Stock. This strategic move is designed to enhance the Company's financial flexibility and support its ongoing growth initiatives.
The offering consists of depositary shares, each representing a 1/100th interest in a share of the Series A Preferred Stock. The pricing of these depositary shares is set to attract a diverse range of investors, further solidifying Microchip's position in the market. The Company aims to use the proceeds from this offering for general corporate purposes, which may include funding for research and development, capital expenditures, and potential acquisitions.
Microchip's management expressed confidence that this offering will not only strengthen its balance sheet but also provide additional resources to drive innovation and expand its product portfolio. As the semiconductor industry continues to evolve, Microchip remains committed to delivering cutting-edge solutions to its customers.
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...